Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis-Reference-Cited by-同舟云学术

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

Published:2020-03 Issue:3 Volume:18 Page:620-627.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Pineton de Chambrun Guillaume,Amiot Aurélien,Bouguen Guillaume,Viennot Stéphanie,Altwegg Romain,Louis Edouard,Collins Michael,Fumery Mathurin,Poullenot Florian,Armengol Laura,Buisson Anthony^ORCID,Abitbol Vered,Laharie David,Seksik Philippe,Nancey Stéphane,Blanc Pierre,Bouhnik Yoram,Pariente Benjamin,Peyrin-Biroulet Laurent,Nachury Maria,Boschetti Gilles,Flourié Bernard,Danion Pauline,Savoye Guillaume,brazier Franck,Loreau Julien,Beaugerie Laurent,Sokol Harry,Nion-Larmurier I.,Bourrier A.,Landman C.,Lefèvre J.,Chafai N.,Bouta Najima,Funakoshi Natalie

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Ulcerative colitis;Ordas;Lancet,2012

2. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII);Meucci;Am J Gastroenterol,2000

3. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications;Satsangi;Gut,2006

4. Ulcerative proctitis: an update on the pharmacotherapy and management;Gecse;Expert Opin Pharmacother,2014

5. The treatment of refractory ulcerative colitis;Pineton de Chambrun;Best Pract Res Clin Gastroenterol,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry;Alimentary Pharmacology & Therapeutics;2024-06-28

2. Management of proctitis in ulcerative colitis and the place of biological therapies;Expert Opinion on Biological Therapy;2024-06-02

3. Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme;Journal of Crohn's and Colitis;2024-04-13

4. Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis;Digestive Diseases and Sciences;2024-02-15

5. Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study;Clinical Gastroenterology and Hepatology;2024-01